首页> 外国专利> t cells therapeutic agents for transmissible spongiform encephalopathy and method for manufacture of non infectious blood products and tissue derived products

t cells therapeutic agents for transmissible spongiform encephalopathy and method for manufacture of non infectious blood products and tissue derived products

机译:用于传染性海绵状脑病的t细胞治疗剂以及非感染性血液制品和组织衍生制品的制造方法

摘要

B-cells have been identified as being the crucial carriers of infectivity in the spread of transmissible spongiform encephalopathy within an infected animal. In a second step, B-cells may infect further component of the immune system, e.g. T-cells. Accordingly, the present invention provides B-cell and T-cell specific ligands for the use in diagnostics and therapeutics for transmissible spongiform encephalopathy and povides methods for the manufacture of non-infective blood products and tissue derived products. Thus, the present invention provides medicaments comprising B-cell and/or T-cell depletants, for the treatment of pathologies where the depletion of B-cells and/or T-cells, and more particularly of infective B-cells and/or T-cells is therapeutically effective. IMAGE
机译:B细胞已被确定为传染性海绵状脑病在感染动物中传播的重要传染性载体。在第二步骤中,B细胞可感染免疫系统的其他成分,例如,B细胞。 T细胞。因此,本发明提供了用于传染性海绵状脑病的诊断和治疗的B细胞和T细胞特异性配体,并提供了制造非感染性血液制品和组织衍生制品的方法。因此,本发明提供了包含B细胞和/或T细胞耗竭剂的药物,用于治疗其中B细胞和/或T细胞耗竭,更特别是感染性B细胞和/或T耗竭的病理学。 -细胞治疗有效。 <图像>

著录项

  • 公开/公告号DE69739344D1

    专利类型

  • 公开/公告日2009-05-14

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF ZURICH;

    申请/专利号DE19976039344T

  • 申请日1997-12-16

  • 分类号A61K39/395;G01N33/53;A61K31/415;A61K31/4166;A61K31/4427;A61K31/57;A61K31/675;A61K35/12;A61K35/14;A61K35/16;A61K38;A61K38/13;A61K39;A61K45;A61P25;A61P31;A61P43;C07K14/435;C07K16/28;C12N5/06;C12P21/08;G01N33/543;G01N33/569;G01N33/68;

  • 国家 DE

  • 入库时间 2022-08-21 19:07:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号